Tenecteplase in prosthetic mitral valve thrombosis
Open Access
- 30 April 2011
- journal article
- research article
- Published by Saudi Heart Association in Journal of the Saudi Heart Association
- Vol. 23 (2) , 93-95
Abstract
In the few reported cases of prosthetic mitral valve thrombosis, where surgical intervention was considered as high risk, fibrinolytic therapy had proved life saving. The authors present clinical, laboratory, and imaging data from such a patient, with prosthetic mitral valve thrombosis and its successful management with tenecteplase. The use of tenecteplase as a viable fibrinolytic agent for the first time was justified, due to the lack of immunogenicity concerns compared to streptokinase.Keywords
This publication has 6 references indexed in Scilit:
- 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2008
- 27-jährige Schwangere mit Synkope und Dyspnoe nach Aortenklappenersatz vor 15 JahrenDie Innere Medizin, 2008
- Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patientsJournal of Thrombosis and Thrombolysis, 2006
- Recurrent obstructive mechanical valve thrombosis in mitral positionInternational Journal of Cardiology, 2001
- Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected prosthetic heart valve thrombosisThe American Journal of Cardiology, 2000
- Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic and transesophageal echocardiographic parametersJACC, 1998